Hi traders,

Semiconductors have become the ATM of this market. VanEck Semiconductor ETF (SMH) delivered years' worth of expected returns in two months. The money is walking out the door to fund whatever works next.

The Magnificent Seven names are getting the same treatment. Hedge funds have been dumping big tech at the fastest pace on record, and that cash isn't going to the sidelines. It's rotating.

You can watch it happen on a vol-adjusted sector board (a ranking that scores sectors by how much they move relative to their risk). Biotech has sat near the top of my 30-day rankings for two weeks. iShares Biotech ETF (IBB) and SPDR Biotech ETF (XBI) are both up double digits while SMH sits red.

That's not noise. That's a funding trade: sell the crowded winner, buy the ignored group with room to run.

Here's the thing about the ATM. Nobody empties the account in one withdrawal. There's still juice left in semis, so this rotation has more room to go.

This week's picks come straight off that read. I love the freshest name breaking out on the receiving end of the money, and I'm leaving one of the names funding it.

One to Love: The Seven-Month Breakout

CRISPR Therapeutics (CRSP) is my long, and it came right off the rotation board. I sold my XBI last week, rotated into Gilead (GILD) and Biogen (BIIB), then went hunting for individual names with more upside. This one has the best setup of the bunch.

Pull up a daily chart. CRSP has been consolidating since December, banging its head on the same trend line for seven months. Today it's punching through, up six percent and taking out that line with authority.

When a stock coils that long and finally breaks, the move tends to travel. The October high near 80 is the obvious magnet, which leaves plenty of room above.

One day is not a trend. But a breakout from a seven-month base (a long stretch of sideways trading that builds pressure) inside a group clearly catching the rotation money is exactly the kind of early entry worth a swing.

I'm long the July 62 and August 65 calls (options that pay off if the stock rises). That's defined risk: the most I can lose is what I paid. If biotech keeps leading, this is the type of name that plays catch-up fast.

One to Leave: The Monster That's Rolling Over

Now for the neck-sticking-out part. My leave is Advanced Micro Devices (AMD), and it's time to move on. The rally in semis was unprecedented, which makes me think the exit will be just as relentless.

AMD ran from under 200 in March to nearly 585 by the end of June. Roughly a triple in four months. Then came a false breakout to new highs this past Tuesday.

Earnings land August 4, and I don't expect a rally into them. That's the ATM account balance, and the withdrawals have started.

The stock is down 28 bucks today, trading below its 21-day moving average (the average price over the last 21 sessions) while the 9-day rolls over. When a monster winner starts losing its short-term trend, that's the market telling you the easy money is gone.

Could AMD go higher? Sure. But the question is never whether it can go up.

It's whether this is the best home for your next dollar. With money visibly leaving semis to fund fresher trades, holding AMD here means volunteering to be the source of someone else's rally.

Take the win. Go find what they're buying with it.

That's the exact call I bring to the Ticker Highlight Show every Monday, where five of us put our love-and-leave picks on the board and narrow the whole thing down to one high-probability options trade, live at 10:30 AM ET.

Come see which name survives the cut.

Enjoy the process,

Tim